Newest A-Z
CONTRIBUTE - Switch from OFF-label to IN-label therapies for rare autoimmune diseases
>Federal Joint Committee | Innovation Fund
Care trajectoriesStatistical Analyses
OnCoPaTh – OncoCoaching and early palliative care in the therapy of incurable cancer
>Federal Joint Committee | Innovation Fund
Care trajectoriesStatistical Analyses
TOP – Transsectoral optimization of patient safety
>Federal Joint Committee | Innovation Fund
Care trajectoriesPharmacotherapy
CoRe-Web – Implementation and Evaluation of an Online Platform for Research Data
>Central Research Institute of Ambulatory Health Care in Germany (Zi)
Care trajectoriesEvaluation
GestDiNa_basic – Aftercare for gestational diabetes
>Federal Joint Committee | Innovation Fund
Care trajectoriesDisease incidence
CoRe-Net – Cologne Research and Development Network
>Federal Ministry of Education and Research BMBF
Care trajectoriesPopulation health
REVASK – Care analysis for myocardial revascularization therapy
>Federal Joint Committee | Innovation Fund
Care trajectoriesData linkage
EVITA – Evidence-based multi-medication program
>Federal Joint Committee | Innovation Fund
Care trajectoriesDevelopment of Guidelines
DiViDe - Frequency of Diagnosis and Care of Hearing Impairment in Children and Adolescents in Germany
>KIND Hearing Foundation, International Hearing Foundation
Care trajectoriesDisease incidence
K-APAT – Outpatient parenteral antibiotic therapy in the Cologne metropolitan region
>Federal Joint Committee | Innovation Fund
Care trajectoriesData preparation
Improvement of emergency care for heart attack patients in Berlin and Brandenburg
>Berlin-Brandenburg myocardial infarction registry
Care trajectoriesPseudonymisation
Evaluation of data from quality assurance stroke Baden-Württemberg
>University Hospital Heidelberg
Care trajectoriesStatistical Analyses
Gestational diabetes
>Zentralinstitut für die Kassenärztliche Versorgung in Deutschland Zi
Care trajectoriesPrevention
Analysis of the prescription of Valproat and related substances over time
>Federal Institute for Drugs and Medical Devices BfArM
Care trajectoriesPharmacotherapy
APVEL – Evaluation of specialised outpatient palliative care
>Federal Joint Committee | Innovation Fund
Care trajectoriesEvaluation
Chronic rheumatic diseases in women of childbearing age
>UCB Pharma GmbH
Care trajectoriesStatistical Analyses
Operationalisation and frequency estimation of a statin intolerance
>Sanofi-Aventis Deutschland GmbH
Care trajectoriesStatistical Analyses
METHODS
TOPICS
DATA
